Tag: OIG

OIG

Washington Focus

Medicare Advantage Plans May Promise More but Deliver Less

Medicare Advantage Plans May Promise More but Deliver Less

May 2, 2022 – Although Medicare Advantage (MA) plans often are touted for delivering more benefits at a lower cost than traditional Medicare, some critics argue that MA organizations (MAOs) deny beneficiaries coverage that they would receive under Medicare rules – including MRIs and post-acute care – in order to increase profits. As MA plan […]

Read more

General

PhRMA’s Updated Code for Industry Addresses Speaker Programs, Meals

PhRMA’s Updated Code for Industry Addresses Speaker Programs, Meals

Aug. 20, 2021 — The Pharmaceutical Research and Manufacturers of America (PhRMA) has “updated and enhanced” its voluntary code of ethics regarding how the drug industry can appropriately interact with U.S. health care professionals (HCPs) while marketing biopharma products in various ways, including speaker programs. PhRMA’s revised “Code on Interactions with Health Care Professionals,” last updated […]

Read more

Regulatory/FDA

HHS OIG Releases Fraud Alert on Speakers Bureaus

HHS OIG Releases Fraud Alert on Speakers Bureaus

Nov. 20, 2020 – In a rare special fraud alert issued Nov. 16, the Department of Health and Human Services Office of Inspector General (OIG) expresses skepticism about the value of company-sponsored speaker bureau events, outlines its concerns about “inherent fraud and abuse risks” associated with these programs, and offers a non-exhaustive list of the […]

Read more